Stay updated with breaking news from Nasdaq Prct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PROCEPT BioRobotics (NASDAQ:PRCT – Get Rating) had its price objective dropped by equities researchers at Wells Fargo & Company from $52.00 to $43.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 17.87% […]
PROCEPT BioRobotics (NASDAQ:PRCT – Get Rating) and LENSAR (NASDAQ:LNSR – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Analyst Ratings This is a summary of current recommendations and […]
PROCEPT BioRobotics (NASDAQ:PRCT – Get Rating) and Pulmonx (NASDAQ:LUNG – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Analyst Ratings This is a breakdown of recent ratings and […]
Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Rating) have been given a consensus recommendation of “Buy” by the six brokerages that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price target among […]
PROCEPT BioRobotics (NASDAQ:PRCT – Get Rating) issued its quarterly earnings data on Thursday. The company reported ($0.39) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.08, MarketWatch Earnings reports. Shares of PRCT traded up $0.18 during midday trading on Friday, reaching $35.31. The stock had a trading volume of 576,093 shares, compared […]